Dr. JoEllen Speca
Claim this profileUNC Rex Healthcare
Studies Breast Cancer
Studies Recurrence
3 reported clinical trials
7 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
ER positive
2Recurrence
PR positive
ER positive
HER2 negative
Affiliated Hospitals
Clinical Trials JoEllen Speca is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Molecular Subtyping
for Metastatic Breast Cancer
The HARMONY trial is an interventional trial enrolling metastatic breast cancer (MBC). Current treatment of breast cancer uses clinical subtype information (e.g. hormone receptor-positive (HR+)) to help guide treatment options. Breast cancer can also be characterized by molecular subtype, but it is not known if this information is helpful in determining treatment when breast cancer has become metastatic. HARMONY will give the treating physician of each participant the molecular subtype of the tumor based on PAM50 testing. The usefulness of this information will be determined through the physician survey. Finding out the molecular subtype of each tumor also allows the investigators to determine if the molecular subtype is different from what is expected based on the clinical subtype. This study will help determine how new types of information about tumors can help choose treatments for MBC
Recruiting1 award N/A11 criteria
More about JoEllen Speca
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments JoEllen Speca has experience with
- Intrinsic Subtyping Of Primary Breast Cancer
- Doxorubicin Hydrochloride
- Cyclophosphamide
- Paclitaxel
- Carboplatin
- Ovarian Function Suppression + Aromatase Inhibitor
Breakdown of trials JoEllen Speca has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does JoEllen Speca specialize in?
JoEllen Speca focuses on Breast Cancer and Recurrence. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is JoEllen Speca currently recruiting for clinical trials?
Yes, JoEllen Speca is currently recruiting for 2 clinical trials in Raleigh North Carolina. If you're interested in participating, you should apply.
Are there any treatments that JoEllen Speca has studied deeply?
Yes, JoEllen Speca has studied treatments such as Intrinsic Subtyping of Primary Breast Cancer, Doxorubicin Hydrochloride, Cyclophosphamide.
What is the best way to schedule an appointment with JoEllen Speca?
Apply for one of the trials that JoEllen Speca is conducting.
What is the office address of JoEllen Speca?
The office of JoEllen Speca is located at: UNC Rex Healthcare, Raleigh, North Carolina 27607 United States. This is the address for their practice at the UNC Rex Healthcare.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.